74 - Hot Topics in Antimicrobial Stewardship

Thursday, October 20, 2022

1:45 PM – 3:00 PM US ET

Location: 143 ABC

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Twisha Patel, PharmD, BCIDP

Subject Matter Expert / Infectious Diseases Pharmacist, International Infection Control Program
Chenega Enterprise Systems and Solutions (CHESS) / Centers for Disease Control and Prevention
Ann Arbor, MI, United States

Disclosure(s): No financial relationships to disclose
Cynthia Nguyen, PharmD

Infectious Diseases Clinical Pharmacy Specialist
University of Chicago Medicine
Chicago, IL, United States

Disclosure(s): Roche Diagnostics: Advisor/Consultant (Ongoing)

Faculty(s)

Kayla Stover Hielscher, PharmD

Professor of Pharmacy Practice
University of Mississippi School of Pharmacy
Madison, MS, United States

Disclosure(s): Cidara Therapeutics Inc.: Advisor/Consultant (Terminated)
Melissa Johnson, PharmD

Associate Professor of Medicine
Duke Center for Antimicrobial Stewardship and Infection Prevention
Duke University School of Medicine
Durham, North Carolina, United States

Disclosure(s): Biomeme: Licensed Transcriptional Signature for Candidemia (Ongoing); Charles River Laboratories: Grant/Research Support (Ongoing); Entasis Therapeutics: Advisor/Consultant (Terminated); Merck & Co. Inc: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer, Inc.: Advisor/Consultant (Terminated); Scynexis Inc.: Grant/Research Support (Ongoing); Theratechnologies: Advisor/Consultant (Terminated)

Slides
jason Pogue, PharmD

Clinical Professor
University of Michigan, College of Pharmacy
Ann Arbor, Michigan, United States

Disclosure(s): Abbvie: Advisor/Consultant (Ongoing); Ferring/Rebiotix Pharmaceuticals: Advisor/Consultant (Ongoing); GlaxoSmithKline Inc.: Advisor/Consultant (Ongoing); La Jolla Pharmaceuticals: Advisor/Consultant (Ongoing); Melinta Therapuetics: Advisor/Consultant (Ongoing); Merck and Company, Inc.: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Qpex Biopharma: Advisor/Consultant (Ongoing); Shionogi & Co.,Ltd.: Advisor/Consultant (Ongoing)

Slides

Disclosure(s):

Twisha S. Patel, PharmD, BCIDP: No financial relationships to disclose

Cynthia T. Nguyen, PharmD: Roche Diagnostics: Advisor/Consultant (Ongoing)

Kayla R. Stover Hielscher, PharmD: Cidara Therapeutics Inc.: Advisor/Consultant (Terminated)

Melissa D. Johnson, PharmD: Biomeme: Licensed Transcriptional Signature for Candidemia (Ongoing); Charles River Laboratories: Grant/Research Support (Ongoing); Entasis Therapeutics: Advisor/Consultant (Terminated); Merck & Co. Inc: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer, Inc.: Advisor/Consultant (Terminated); Scynexis Inc.: Grant/Research Support (Ongoing); Theratechnologies: Advisor/Consultant (Terminated)

jason M. Pogue, PharmD: Abbvie: Advisor/Consultant (Ongoing); Ferring/Rebiotix Pharmaceuticals: Advisor/Consultant (Ongoing); GlaxoSmithKline Inc.: Advisor/Consultant (Ongoing); La Jolla Pharmaceuticals: Advisor/Consultant (Ongoing); Melinta Therapuetics: Advisor/Consultant (Ongoing); Merck and Company, Inc.: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Qpex Biopharma: Advisor/Consultant (Ongoing); Shionogi & Co.,Ltd.: Advisor/Consultant (Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

evaluate the evidence for historically unusual bug-drug matches in the context of antimicrobial stewardship;
evaluate the evidence for addition of antimicrobial therapy with activity against Candida and Enterococcus for the treatment of intraabdominal infections;
develop a customized institutional antibiogram that clinicians can use as a resource when prescribing empiric antimicrobial therapy

Presentations:

1:45 PM – 2:10 PM US ET

This Drug for That Bug: Really? An Evidence-Based Discussion of Antimicrobial Activity Relevant to Antimicrobial Stewardship
Speaker: Kayla R. Stover Hielscher, PharmD – University of Mississippi School of Pharmacy
2:10 PM – 2:35 PM US ET

Intraabdominal Infections: When Is Candida and Enterococcus Coverage Necessary?
Speaker: Melissa D. Johnson, PharmD – Duke University School of Medicine
2:35 PM – 3:00 PM US ET

Antibiograms: Drug, Bug, Is That Really It?
Speaker: jason M. Pogue, PharmD – University of Michigan, College of Pharmacy